Longevity Health Inc.

NASDAQ: XAGE · Real-Time Price · USD
2.77
0.07 (2.59%)
At close: Aug 26, 2025, 3:59 PM
2.76
-0.36%
After-hours: Aug 26, 2025, 05:05 PM EDT

Longevity Health Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021
Revenue
503.61K 510.35K 17.48K 20.52K 12.32K n/a -3.73M 3.73M n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost of Revenue
200.95K 240.53K 1.23K 4.84K 292.00 57.57K n/a 1.54M n/a n/a n/a n/a n/a n/a n/a n/a n/a
Gross Profit
302.66K 269.82K 16.25K 15.68K 12.03K -57.57K -3.73M 2.18M n/a n/a n/a n/a n/a n/a n/a n/a n/a
Operating Income
-1.86M -1.51M -1.01M -1.42M -1.19M -1.38M 1.96M -4.41M -1.16M -756.47K -2.79M -851.92K -285.88K -535.14K -369.9K -89.96K -6.37K
Interest Income
n/a n/a n/a n/a n/a n/a n/a n/a 1.87M 1.68M 1.34M 698.28K n/a n/a n/a n/a n/a
Pretax Income
-1.89M -1.51M -1.01M -2.88M -3.3M -3.55M 2.4M -11.46M 706.14K 919.39K -3.12M -6.07M -80.58K -527.53K -234.5K -87.3K -6.37K
Net Income
-1.89M -1.51M -914.28K -2.88M -3.3M -3.27M 3.16M -11.46M 317.51K 576.07K -3.12M -6.07M -346.99K -527.53K -234.5K -87.3K -6.37K
Selling & General & Admin
1.91M 1.56M 815.67K 1.09M 1.08M 927.39K -3.02M 4.49M 1.16M 756.47K 2.12M 257.37K 285.88K 535.14K 369.9K 89.96K n/a
Research & Development
228.61K 196.91K 189.02K 331.81K 104.07K 429.42K -738.67K 1.67M 823.66K 740.33K 641.46K 570.93K n/a n/a n/a n/a n/a
Other Expenses
22.18K 23.95K 18.45K 17.98K 23.53K -34.04K -1.93M 429.48K -461 34.54K 39.00 9.00 n/a n/a n/a n/a -6.37K
Operating Expenses
2.16M 1.78M 1.02M 1.44M 1.2M 1.32M -5.68M 6.6M 1.16M 756.47K 2.79M 851.92K 285.88K 535.14K 369.9K 89.96K -6.37K
Interest Expense
2.56K 4.99K 7.51K 7.12K 9.35K 25.03K -47.7K 397.68K 276.03K 263.3K 327.26K 1.49M n/a n/a n/a n/a n/a
Selling & Marketing Expenses
345.5K 280.55K 58.22K 120.06K 11.04K n/a -3.07M 3.07M n/a 246.02K n/a n/a n/a n/a -7.58K n/a n/a
Cost & Expenses
2.36M 2.02M 1.02M 1.44M 1.2M 1.38M -5.68M 8.14M 1.16M 756.47K 2.79M 851.92K 285.88K 535.14K 369.9K 89.96K -6.37K
Income Tax Expense
n/a n/a -97.28K n/a n/a n/a n/a n/a 388.63K 343.33K n/a n/a 266.41K n/a n/a n/a n/a
Shares Outstanding (Basic)
1.21M 20.91M 20.91M 20.91M 20.74M 22.92M 20.77M 18.63M 19.77M 19.77M 19.77M 19.24M 19.24M 19.77M 19.77M 19.77M 19.31M
Shares Outstanding (Diluted)
1.21M 20.91M 20.91M 20.91M 20.74M 22.92M 20.77M 18.63M 19.77M 19.77M 19.77M 19.24M 19.24M 19.77M 19.77M 19.77M 19.31M
EPS (Basic)
-1.56 -0.07 -0.04 -0.14 -0.16 -0.21 0.15 -0.62 0.02 0.03 -0.16 -0.32 -0.02 -0.03 -0.01 -0.00 -0.00
EPS (Diluted)
-1.56 -0.07 -0.04 -0.14 -0.16 -0.21 0.15 -0.62 0.02 0.03 -0.16 -0.32 -0.02 -0.03 -0.01 -0.00 -0.00
EBITDA
-1.82M -1.43M -965.51K -2.83M -3.24M -3.47M 2M -10.64M -3.03M -1.51M -2.73M -828.29K -491.17K -527.53K -234.5K -87.3K -6.37K
EBIT
-1.88M -1.5M -1M -2.87M -3.3M -3.53M 2.35M -11.07M -5.03M -1.57M -2.79M -4.57M -285.88K -527.53K -234.5K -87.3K n/a
Depreciation & Amortization
65.6K 73.71K 38.54K 42.88K 58.27K 57.57K -349.38K 423.8K -1.87M 59.91K 59.59K 23.62K -205.3K 7.61K 141.76K 2.65K 55.81K